NHSP 2017- 2022 (Final draft)
This toolkit consists of eight modules which have been prepared as stand-alone documents that can be read by themselves, but they have also been prepared to complement one another. It has been designed as a tool for health professionals and students in the health care and public health sectors who ...want to engage more directly on the issue of climate change as educators with their patients, peers and communities, and/or as advocates for the policies, programs and practices needed to mitigate climate change and/or prepare for climate change in their workplaces and communities
more
Für viele Städte ist eine klimafreundliche Mobilität eine Herausforderung, der sie sich zunehmend stellen. Viele Fragen stehen im Raum: wie sieht Mobilität und eine Stadt von morgen aus? Wie komme ich klima- und umweltfreundlich zur Schule und zur Arbeit? Was für eine Wende ist dafür nötig un...d wie könnte diese aussehen? Das Unterrichtsmaterial „Verkehr(t)!“ regt die Schüler*innen dazu an, das Verkehrsverhalten in ihrer Umwelt zu analysieren und ihre eigene Mobilität kritisch unter die Lupe zu nehmen. Sie erkunden, welche Bedeutung Verkehr für Umwelt und Klima hat und identifizieren Stellen, an denen Handeln möglich und notwendig ist.
more
The Urban Health Equity Assessment and Response Tool (Urban HEART) is a user-friendly guide for policy- and decision-makers at national and local levels to: identify and analyse inequities in health between people living in various parts of cities, or belonging to different socioeconomic groups with...in and across cities; facilitate decisions on viable and effective strategies, interventions and actions that should be used to reduce inter- and intra-city health inequities.
Also available in French and Spanish: https://apps.who.int/iris/handle/10665/79060
more
Primary care - Putting people first: This chapter describes how primary care brings promotion and prevention, cure and care together in a safe, effective and socially productive way at the interface between the population and the health system.
What is Violence Against Women? Why does it happen? What does it have to do with development? What does Oxfam do to end violence against women? What does it mean to do that work with a transformative approach?
Available in: English, Arabic, French, Spanish: https://policy-practice.oxfam.org.uk/publ...ications/ending-violence-against-women-an-oxfam-guide-254118
more
State of Health in the EU Cycle.
With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for policymakers to plan effective strategies to re-open their economies to avoid further re-confinement...s. This should include much more effective testing, tracing and isolation policies that people can easily follow, as well as improved social distancing measures
more
Constraints, Technologies, Policies and Processes
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Washington (DC): National Academies Press (US); 2001.
This report provides insights into the prevalence of belief systems and gender norms among young women and men in the region. It looks in depth at the most entrenched beliefs and behaviours among the younger population and provides ample evidence that we must challenge and change the prevailing beli...ef systems and gender norms if we are to make real progress in guaranteeing the right of all women and girls to a life free from violence.
more
This report considers how to integrate health into urban planning, investments, and policy decisions, so as to support the implementation and achievement of the goals and objectives of the New Urban Agenda.
The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re...sult of extensive consultations with more than 30 African government ministers, technical actors, partners across the continent as well as regional institutions such as the Africa Centres for Disease Control and Prevention (Africa CDC), whose contributions have shaped the priority activities. This report provides the second quarterly summary of progress in implementing the flagship programmes.
more
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are... committed to pursue as members of the UN. We address this Commission report to the UN member states, the UN agencies and multilateral institutions, and multilateral processes such as the G20 and the G7.
more
La demencia es una enfermedad gravemente incapacitante para aquellos que la padecen y suele ser devastadora para sus cuidadores y familiares. Se estima que en la actualidad 35.6 millones de personas viven con demencia a nivel mundial. Este número se habrá casi duplicado para el 2030 y más que tri...plicado para el 2050. La alta prevalencia mundial y el impacto económico de la demencia en las familias, los cuidadores y las comunidades, así como el estigma y la exclusión social asociados, presentan un importante reto para la salud pública.
more
dades infecciosas. Los antimicrobianos eficaces son imprescindibles para las medidas preventivas y curativas, para proteger a los pacientes frente a enfermedades potencialmente mortales y para garantizar que se puedan llevar a cabo procedimientos complejos, como la cirugía y la quimioterapia, con e...scasos riesgos. Sin embargo, el mal uso y el abuso sistemático de estos fármacos en la medicina y la producción de alimentos han puesto en riesgo a todas las naciones. Hay pocos productos de recambio en fase de investigación y desarrollo. Sin medidas armonizadas e inmediatas a escala mundial avanzamos hacia una era posantibiótica en la que infecciones comunes podrían volver a ser mortales.
more
The WHO EMRO webpage on the "Regional framework for action" outlines strategies for addressing noncommunicable diseases (NCDs) within the Eastern Mediterranean region. The framework provides a roadmap for countries to reduce the prevalence and impact of NCDs such as cardiovascular diseases, diabetes..., cancer, and respiratory illnesses. It emphasizes preventive measures, health promotion, and the integration of NCD management into primary healthcare systems. Key components include policy development, surveillance, and the mobilization of resources to support sustainable NCD initiatives. The framework aims to strengthen regional collaboration to improve health outcomes related to NCDs.
more
This video highlights the significant risks that malaria poses to pregnant and breastfeeding women in malaria-endemic regions. It follows the stories of Angavu from Kenya, Moyinoluwa from Nigeria and Lamai from Thailand. It emphasises the severe consequences that malaria can have during pregnancy, i...ncluding miscarriage, stillbirth, low birth weight and maternal death. Due to safety concerns, pregnant women are often excluded from antimalarial drug trials, which causes long delays in effective medicines becoming available for this vulnerable group. To address this issue, the Medicines for Malaria Venture (MMV) launched the Malaria in Mothers and Babies (MiMBa) initiative, which aims to accelerate the discovery, development, and delivery of safe antimalarial treatments for pregnant and breastfeeding women. The initiative aims to close critical gaps in research, drug development, and access, ensuring that these women and their babies are better protected against malaria. The video calls for continued efforts to address the needs of underserved populations most affected by malaria.
more
L’initiative Médicaments contre les Maladies Négligées (DNDi) est une organisation internationale à but non lucratif spécialisée dans la recherche, le développement et la mise à disposition de traitements sûrs, efficaces et abordables aux patients les plus négligés.